Cassava Sciences, Inc.
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational dia…
Government Awards Analysis Beta
It's important to keep an eye on government contracts, because they can make up a substantial portion
of total sales for your researched company.
The Data for the government spending analysis is directly sourced from the
US gov. application interface.
Obligations Over-Time
Cassava Sciences, Inc. has no obligation with a government/award agency.
Latest Obligations
Spending By Type
Cassava Sciences, Inc. can't present spending by time.
Get PRO Today
With PRO you will unlock all insights related to government awards of Cassava Sciences, Inc..